DYRK1A and myeloproliferative disorder: As DYRK1A overexpression is orchestrating multiple cellular processes to promote disease progression in MPN (Supplementary Note), it is interesting to speculate which component (amplified JAK–STAT signaling versus increased genomic instability) is dominant.